MSX2 is an oncogenic downstream target of activated WNT signaling in ovarian endometrioid adenocarcinoma.

Abstract:

:Ovarian endometrioid adenocarcinomas (OEAs) frequently exhibit constitutive activation of canonical WNT signaling, usually as a result of oncogenic mutations that stabilize and dysregulate the β-catenin protein. In previous work, we used microarray-based methods to compare gene expression in OEAs with and without dysregulated β-catenin as a strategy for identifying novel β-catenin/TCF target genes with important roles in ovarian cancer pathogenesis. Among the genes highlighted by the microarray studies was MSX2, which encodes a homeobox transcription factor. We found MSX2 expression was markedly increased in primary human and murine OEAs with dysregulated β-catenin compared with OEAs with intact β-catenin regulation. WNT pathway activation by WNT3a ligand or GSK3β inhibitor treatment potently induced MSX2 and ectopic expression of a dominant negative form of TCF4 inhibited MSX2 expression in ovarian cancer cells. Chromatin immunoprecipitation studies demonstrated that β-catenin/TCF directly regulates MSX2 expression via binding to TCF binding elements in multiple regions of the MSX2 gene. Notably, ectopic MSX2 expression was found to promote neoplastic transformation of the rodent RK3E model epithelial cell line and to enhance the invasiveness of immortalized human ovarian epithelial cells in vitro and ovarian carcinoma cells in vivo. Inhibition of endogenous MSX2 expression in ovarian endometrioid cancer cells carrying a β-catenin mutation using shRNA approaches inhibited neoplastic properties of the cells in vitro and in vivo. Expression of MSX2 in selected ovarian carcinoma cells induced changes suggestive of epithelial-mesenchymal transition (EMT), but based on analysis of ovarian cell lines and primary tumor tissues, effects of MSX2 on EMT appear to be complex and context-dependent. Our findings indicate MSX2 is a direct downstream transcriptional target of β-catenin/TCF and has a key contributing role in the cancer phenotype of OEAs carrying WNT/β-catenin pathway defects.

journal_name

Oncogene

journal_title

Oncogene

authors

Zhai Y,Iura A,Yeasmin S,Wiese AB,Wu R,Feng Y,Fearon ER,Cho KR

doi

10.1038/onc.2011.123

subject

Has Abstract

pub_date

2011-10-06 00:00:00

pages

4152-62

issue

40

eissn

0950-9232

issn

1476-5594

pii

onc2011123

journal_volume

30

pub_type

杂志文章

相关文献

ONCOGENE文献大全
  • Cholecystokinin-2 receptor modulates cell adhesion through beta 1-integrin in human pancreatic cancer cells.

    abstract::Several lines of evidence suggest that gastrin and the CCK-2 receptor (CCK2R) could contribute to pancreatic carcinogenesis by modulating processes such as proliferation, cell adhesion or migration. In the current study, we used a 'cancer gene array' and identified beta1-integrin subunit as a new gastrin-regulated gen...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209484

    authors: Cayrol C,Clerc P,Bertrand C,Gigoux V,Portolan G,Fourmy D,Dufresne M,Seva C

    更新日期:2006-07-27 00:00:00

  • Mysterious liaisons: the relationship between c-Myc and the cell cycle.

    abstract::A large body of physiological evidence shows that either upregulation or downregulation of intracellular c-Myc activity has profound consequences on cell cycle progression. Recent work suggests that c-Myc may stimulate the activity of cyclin E/cyclin-dependent kinase 2 (Cdk2) complexes and antagonize the action of the...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1202749

    authors: Obaya AJ,Mateyak MK,Sedivy JM

    更新日期:1999-05-13 00:00:00

  • Tumor formation in mice with somatic inactivation of the retinoblastoma gene in interphotoreceptor retinol binding protein-expressing cells.

    abstract::The retinoblastoma suppressor gene product Rb has been assigned a critical role in cell cycle regulation, the induction of differentiation, and inhibition of oncogenic transformation. Inheritance of a mutant RB allele in humans is responsible for bilateral retinoblastoma, a malignant tumor of the retina. Trilateral re...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1205575

    authors: Vooijs M,te Riele H,van der Valk M,Berns A

    更新日期:2002-07-11 00:00:00

  • NAD+-dependent deacetylation of H4 lysine 16 by class III HDACs.

    abstract::Histone deacetylases (HDACs) catalyse the removal of acetyl groups from the N-terminal tails of histones. All known HDACs can be categorized into one of four classes (I-IV). The class III HDAC or silencing information regulator 2 (Sir2) family exhibits characteristics consistent with a distinctive role in regulation o...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1210617

    authors: Vaquero A,Sternglanz R,Reinberg D

    更新日期:2007-08-13 00:00:00

  • Co-localization of the TSC2 product tuberin with its target Rap1 in the Golgi apparatus.

    abstract::Tuberin is the protein product of the tuberous sclerosis-2 (TSC2) gene, which is associated with tuberous sclerosis (TSC), a human genetic syndrome characterized by the development of tumors in a variety of tissues. We have previously shown that tuberin is a widely expressed 180 kDa protein which exhibits specific GTP...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Wienecke R,Maize JC Jr,Shoarinejad F,Vass WC,Reed J,Bonifacino JS,Resau JH,de Gunzburg J,Yeung RS,DeClue JE

    更新日期:1996-09-05 00:00:00

  • Prevalence and specificity of LKB1 genetic alterations in lung cancers.

    abstract::Germline LKB1 mutations cause Peutz-Jeghers syndrome, a hereditary disorder that predisposes to gastrointestinal hamartomatous polyposis and several types of malignant tumors. Somatic LKB1 alterations are rare in sporadic cancers, however, a few reports showed the presence of somatic alterations in a considerable frac...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1210418

    authors: Matsumoto S,Iwakawa R,Takahashi K,Kohno T,Nakanishi Y,Matsuno Y,Suzuki K,Nakamoto M,Shimizu E,Minna JD,Yokota J

    更新日期:2007-08-30 00:00:00

  • Characterization of Wnt-1 and Wnt-2 induced growth alterations and signaling pathways in NIH3T3 fibroblasts.

    abstract::Members of the Wnt family induce mouse mammary tumors and partially transform mammary epithelial cells in culture. However, their mechanism of transformation remains to be elucidated. In NIH3T3 mouse embryo fibroblasts, a standard transformation model, Wnt-1 and Wnt-2 were shown to induce altered properties including ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201797

    authors: Bafico A,Gazit A,Wu-Morgan SS,Yaniv A,Aaronson SA

    更新日期:1998-05-28 00:00:00

  • PU.1 binding to the p53 family of tumor suppressors impairs their transcriptional activity.

    abstract::The transcription factor PU.1 is essential for terminal myeloid differentiation, B- and T-cell development, erythropoiesis and hematopoietic stem cell maintenance. PU.1 functions as oncogene in Friend virus-induced erythroleukemia and as tumor suppressor in acute myeloid leukemias. Moreover, Friend virus-induced eryth...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1211004

    authors: Tschan MP,Reddy VA,Ress A,Arvidsson G,Fey MF,Torbett BE

    更新日期:2008-05-29 00:00:00

  • FBXL14 abolishes breast cancer progression by targeting CDCP1 for proteasomal degradation.

    abstract::Understanding the molecular mechanisms that underlie the aggressive behavior and relapse of breast cancer may help in the development of novel therapeutic interventions. CUB-domain-containing protein 1 (CDCP1), a transmembrane adaptor protein, is highly maintained and required in the context of cellular metastatic pot...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-018-0372-3

    authors: Cui YH,Kim H,Lee M,Yi JM,Kim RK,Uddin N,Yoo KC,Kang JH,Choi MY,Cha HJ,Kwon OS,Bae IH,Kim MJ,Kaushik N,Lee SJ

    更新日期:2018-10-01 00:00:00

  • Role of Mdm4 in drug sensitivity of breast cancer cells.

    abstract::The p53 tumor suppressor protein is frequently mutated in human tumors. It is thought that the p53 pathway is indirectly impaired in the remaining tumors, for example by overexpression of its important regulators Mdm2 and Mdm4, making them attractive targets for the development of anti-cancer agents. Recent studies ha...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2009.522

    authors: Lam S,Lodder K,Teunisse AF,Rabelink MJ,Schutte M,Jochemsen AG

    更新日期:2010-04-22 00:00:00

  • Elevated expression of the junB proto-oncogene is essential for v-fos induced transformation of Rat-1 cells.

    abstract::We previously described the isolation of non-tumorigenic revertants from mutagenized populations of v-fos-transformed Rat-1 cells (Zarbl et al., 1987). In the present study we examined the possibility that the revertant phenotype resulted from mutations that altered the expression or activities of the c-jun or junB pr...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Van Amsterdam JR,Wang Y,Sullivan RC,Zarbl H

    更新日期:1994-10-01 00:00:00

  • Genetic models of osteochondroma onset and neoplastic progression: evidence for mechanisms alternative to EXT genes inactivation.

    abstract::Osteochondroma, the most common benign bone tumor, may occur as a sporadic lesion or as multiple neoplasms in the context of multiple osteochondromas syndrome. The most severe complication is malignant transformation into peripheral secondary chondrosarcoma. Although both benign conditions have been linked to defects ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2010.135

    authors: Zuntini M,Pedrini E,Parra A,Sgariglia F,Gentile FV,Pandolfi M,Alberghini M,Sangiorgi L

    更新日期:2010-07-01 00:00:00

  • A novel protein, RTN-XS, interacts with both Bcl-XL and Bcl-2 on endoplasmic reticulum and reduces their anti-apoptotic activity.

    abstract::Bcl-2 and Bcl-XL serve as critical inhibitors of apoptosis triggered by a broad range of stimuli, mainly acting on the mitochondria. We identified two members of the reticulon (RTN) family as Bcl-XL binding proteins, i.e., NSP-C (RTN1-C) and a new family member, RTN-XS, both of which did not belong to the Bcl-2 family...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203948

    authors: Tagami S,Eguchi Y,Kinoshita M,Takeda M,Tsujimoto Y

    更新日期:2000-11-23 00:00:00

  • p53 point mutation in HPV negative human cervical carcinoma cell lines.

    abstract::Clinical and experimental evidence is consistent with a key role for transforming human papilloma viruses (HPVs) in the aetiology of anogenital carcinoma. Cervical carcinoma does, however, occasionally occur in the absence of HPV sequences (Riou et al., 1990). We have used a direct cDNA/PCR sequencing protocol to anal...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Crook T,Wrede D,Vousden KH

    更新日期:1991-05-01 00:00:00

  • Over-representation of a germline variant in the gene encoding RET co-receptor GFRalpha-1 but not GFRalpha-2 or GFRalpha-3 in cases with sporadic medullary thyroid carcinoma.

    abstract::In contrast to the hereditary form of medullary thyroid carcinoma (MTC), little is known about the etiology of sporadic MTC. Somatic gain-of-function mutations in the RET proto-oncogene, encoding a receptor tyrosine kinase, are found in an average of 40% of sporadic MTC. We analysed 31 sporadic MTC for somatic and ger...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204289

    authors: Gimm O,Dziema H,Brown J,Hoang-Vu C,Hinze R,Dralle H,Mulligan LM,Eng C

    更新日期:2001-04-19 00:00:00

  • Midkine (MDK) growth factor: a key player in cancer progression and a promising therapeutic target.

    abstract::Midkine is a heparin-binding growth factor, originally reported as the product of a retinoic acid-responsive gene during embryogenesis, but currently viewed as a multifaceted factor contributing to both normal tissue homeostasis and disease development. Midkine is abnormally expressed at high levels in various human m...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/s41388-019-1124-8

    authors: Filippou PS,Karagiannis GS,Constantinidou A

    更新日期:2020-03-01 00:00:00

  • Tamoxifen induces p21WAF1 and p27KIP1 expression in estrogen receptor-negative lung cancer cells.

    abstract::Tamoxifen (Tam), besides its action as an anti-estrogen, also inhibits cell proliferation of estrogen receptor (ER)-negative cancer cells by an unknown mechanism. In this study, we used ER-negative lung cancer cells to clarify such ER-independent inhibitory effect of Tam. We found that Tam induced G1 growth arrest in ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202755

    authors: Lee TH,Chuang LY,Hung WC

    更新日期:1999-07-22 00:00:00

  • A novel CLTC-TFE3 gene fusion in pediatric renal adenocarcinoma with t(X;17)(p11.2;q23).

    abstract::A distinctive subset of renal carcinomas is associated with Xp11. 2 translocations and resulting TFE3 gene fusions (PRCC-TFE3, PSF-TFE3, NONO-TFE3, ASPL-TFE3), encoding related aberrant transcription factors. We report the cloning of a novel clathrin heavy-chain gene (CLTC)-TFE3 gene fusion resulting from a t(X;17)(p1...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206686

    authors: Argani P,Lui MY,Couturier J,Bouvier R,Fournet JC,Ladanyi M

    更新日期:2003-08-14 00:00:00

  • Hepatitis C virus core protein recruits nucleolar phosphoprotein B23 and coactivator p300 to relieve the repression effect of transcriptional factor YY1 on B23 gene expression.

    abstract::Hepatitis C virus (HCV) core has a pleiotropic effect on various promoters. In this study, we found that the expression of nucleolar phosphoprotein B23 was enhanced in HCV core-expressing cells and, moreover, HCV core interacts directly with the C-terminal end of B23. Using sucrose gradient centrifugation analysis and...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209052

    authors: Mai RT,Yeh TS,Kao CF,Sun SK,Huang HH,Wu Lee YH

    更新日期:2006-01-19 00:00:00

  • 2-deoxyglucose-induced toxicity is regulated by Bcl-2 family members and is enhanced by antagonizing Bcl-2 in lymphoma cell lines.

    abstract::Targeting altered cancer cell metabolism with the glycolysis inhibitor, 2-deoxyglucose (2DG), is a viable therapeutic strategy, but the effects of 2DG on lymphoma cells and the mechanism of action are unknown. Five T-cell lymphoma lines and two B-cell lymphoma lines were shown to be highly sensitive to 2DG. Examinatio...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2011.454

    authors: Zagorodna O,Martin SM,Rutkowski DT,Kuwana T,Spitz DR,Knudson CM

    更新日期:2012-05-31 00:00:00

  • Human S100A4 (p9Ka) induces the metastatic phenotype upon benign tumour cells.

    abstract::The rodent S100-related calcium-binding protein, S100A4 induces metastasis in non-metastatic rat and mouse benign mammary cells and co-operates with benign-tumour-inducing changes in two transgenic mouse models, to yield metastatic mammary tumours. Co-transfection of the human gene for S100A4 with pSV2neo into the ben...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201948

    authors: Lloyd BH,Platt-Higgins A,Rudland PS,Barraclough R

    更新日期:1998-07-30 00:00:00

  • Truncated ErbB2 receptor (p95ErbB2) is regulated by heregulin through heterodimer formation with ErbB3 yet remains sensitive to the dual EGFR/ErbB2 kinase inhibitor GW572016.

    abstract::The expression of the NH2 terminally truncated ErbB2 receptor (p95ErbB2) in breast cancer correlates with metastatic disease progression compared with the expression of full-length p185ErbB2. We now show that heregulin (HRG), but not EGF, stimulates p95ErbB2 phosphorylation in BT474 breast cancer cells. Furthermore, p...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207166

    authors: Xia W,Liu LH,Ho P,Spector NL

    更新日期:2004-01-22 00:00:00

  • Targeted inhibition of the Hedgehog pathway in established malignant glioma xenografts enhances survival.

    abstract::Hedgehog pathway activity has been demonstrated in malignant glioma. However, its role in tumor growth has not been determined. Here we demonstrate that pharmacological inhibition of the Hedgehog pathway in established orthotopic malignant glioma xenografts confers a survival advantage. Pathway inhibition is measured ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2009.208

    authors: Sarangi A,Valadez JG,Rush S,Abel TW,Thompson RC,Cooper MK

    更新日期:2009-10-01 00:00:00

  • MTBP suppresses cell migration and filopodia formation by inhibiting ACTN4.

    abstract::Murine double minute (MDM2) binding protein (MTBP) has been implicated in cancer progression. Here, we demonstrate one mechanism by which MTBP inhibits cancer metastasis. Overexpression of MTBP in human osteosarcoma cell lines lacking wild-type p53 did not alter primary tumor growth in mice, but significantly inhibite...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.69

    authors: Agarwal N,Adhikari AS,Iyer SV,Hekmatdoost K,Welch DR,Iwakuma T

    更新日期:2013-01-24 00:00:00

  • Signalling of the Ret receptor tyrosine kinase through the c-Jun NH2-terminal protein kinases (JNKS): evidence for a divergence of the ERKs and JNKs pathways induced by Ret.

    abstract::The RET proto-oncogene encodes a functional receptor tyrosine kinase (Ret) for the Glial cell line Derived Neurotrophic Factor (GDNF). RET is involved in several neoplastic and non-neoplastic human diseases. Oncogenic activation of RET is detected in human papillary thyroid tumours and in multiple endocrine neoplasia ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201778

    authors: Chiariello M,Visconti R,Carlomagno F,Melillo RM,Bucci C,de Franciscis V,Fox GM,Jing S,Coso OA,Gutkind JS,Fusco A,Santoro M

    更新日期:1998-05-14 00:00:00

  • Characterization of a third ras gene, rasB, that is expressed throughout the growth and development of Dictyostelium discoideum.

    abstract::Previous reports have indicated that the cellular slime mold Dictyostelium discoideum possesses two ras genes (rasG and rasD) and one rap gene (rap1). All three genes are developmentally regulated, with each showing a different pattern of transcription during the Dictyostelium life cycle. To establish whether there ar...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Daniel J,Spiegelman GB,Weeks G

    更新日期:1993-04-01 00:00:00

  • The bovine papillomavirus type 1 E6 oncoprotein sensitizes cells to tumor necrosis factor alpha-induced apoptosis.

    abstract::Expression of viral proteins may result in susceptibility of cells to the cytotoxic effect of Tumor Necrosis Factor Alpha (TNF). While murine C127 cells containing the bovine papillomavirus type 1 (BPV-1) genome were reported to exhibit increased TNF sensitivity, the gene(s) responsible was not identified. The BPV-1 E...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202373

    authors: Rapp L,Liu Y,Hong Y,Androphy EJ,Chen JJ

    更新日期:1999-01-21 00:00:00

  • Heat shock protein 70 binding inhibits the nuclear import of apoptosis-inducing factor.

    abstract::Heat shock protein 70 (HSP70) can inhibit apoptosis by neutralizing and interacting with apoptosis-inducing factor (AIF), a mitochondrial flavoprotein that translocates upon apoptosis induction to the nucleus, via the cytosol. Here, we show that only members of the HSP70 family interact with AIF. Systematic deletion m...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206794

    authors: Gurbuxani S,Schmitt E,Cande C,Parcellier A,Hammann A,Daugas E,Kouranti I,Spahr C,Pance A,Kroemer G,Garrido C

    更新日期:2003-10-02 00:00:00

  • Involvement of Myc targets in c-myc and N-myc induced human tumors.

    abstract::The myc proto-oncogenes are transcription factors that directly regulate the expression of other genes, by binding to the specific DNA sequence, CACGTG. Among the target genes for c-Myc regulation are ECA39, p53, ornithine decarboxylase (ODC), alpha-prothymosin and Cdc25A. In this study we examined the involvement of ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201939

    authors: Ben-Yosef T,Yanuka O,Halle D,Benvenisty N

    更新日期:1998-07-16 00:00:00

  • The promyelocytic leukemia protein PML interacts with the proline-rich homeodomain protein PRH: a RING may link hematopoiesis and growth control.

    abstract::Acute promyelocytic leukemia (APL) is characterized by a block in myeloid cell differentiation. As a result of a chromosomal translocation in these patients, the promyelocytic leukemia protein PML is disrupted as are the nuclear bodies it forms. Disruption of PML and PML nuclear bodies in APL is linked to a loss of gr...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203201

    authors: Topcu Z,Mack DL,Hromas RA,Borden KL

    更新日期:1999-11-25 00:00:00